Page 206 - Neuropsychiatric.indd
P. 206

6.  Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and
                   management of acute deep vein thrombosis: a joint consensus document from the

                   European Society of Cardiology working groups of aorta and peripheral vascular diseases
                   and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208-
                   18.
               7.  Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC

                   Guidelines for the diagnosis and management of acute pulmonary embolism developed
                   in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-
                   603.

               8.  Ramot Y, Nyska A, Spectre G. Drug-induced thrombosis: an update. Drug Saf. 2013;36(8):
                   585-603.
               9.  Girolami A, Cosi E, Tasinato V, Santarossa C, Ferrari S, Girolami B. Drug-Induced
                   thrombophilic or prothrombotic states: an underestimated clinical problem that involves
                   both legal and illegal compounds. Clin Appl Thromb Hemost. 2017;23(7):775-85.

               10. Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME. A systematic review and
                   meta-analysis of venous thrombosis risk among users of combined oral contraception. Int
                   J Gynaecol Obstet. 2018;141(3):287-94.

               11. Kim JE, Chang JH, Jeong MJ, Choi J, Park J, Baek C, et al. A systematic review and meta-
                   analysis of effects of menopausal hormone therapy on cardiovascular diseases. Sci Rep.
                   2020;10(1):20631.
               12. Di X, Chen M, Shen S, Cui X. Antipsychotic use and risk of venous thromboembolism: a

                   meta-analysis. Psychiatry Res. 2021;296:113691.
               13. Ungprasert P, Srivali N, Wijarnpreecha K, Charoenpong P, Knight EL. Non-steroidal anti-
                   inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-
                   analysis. Rheumatology (Oxford). 2015;54(4):736-42.

               14. Alahmari AK, Almalki ZS, Alahmari AK, Guo JJ. Thromboembolic events associated with
                   bevacizumab plus chemotherapy for patients with colorectal cancer: a meta-analysis of
                   randomized controlled trials. Am Health Drug Benefits. 2016;9(4):221-32.
               15. Seng S, Liu Z, Chiu SK, Proverbs-Singh T, Sonpavde G, Choueiri TK, et al. Risk of venous

                   thromboembolism in patients with cancer treated with cisplatin: a systematic review and
                   meta-analysis. J Clin Oncol. 2012;30(35):4416-26.
               16. Braithwaite RS, Chlebowski RT, Lau J, George S, Hess R, Col NF. Meta-analysis of vascular
                   and neoplastic events associated with tamoxifen. J Gen Intern Med. 2003;18(11):937-47.

               17. Greene EM, Hagemann TM. Chapter 121 Drug-induced hematologic disorder. In: Dipiro JT
                   et al., eds. Pharmacotherapy: A pathophysiologic approach. 11th ed. United States:
                   McGraw Hill Companies, Inc, 2020.







                                                                                                       185
                                                                                                       185
   201   202   203   204   205   206   207   208   209   210   211